This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Based on AEGEAN Phase III trial results which showed Imfinzi-based regimen reduced the risk of recurrence, progression or death by 32% vs. neoadjuvant chemotherapy alone
The partnership marks a significant milestone in integrating digital health education into medical curricula
Our centers are performing as expected or even better
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
Dr. Jitendra Singh’s pioneering work on “Stress Diabetes in Kashmiri Migrants” was hailed by the World Health Organization
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Reported profit after tax declined 19% year-on-year to Rs 76 crores
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Subscribe To Our Newsletter & Stay Updated
